Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 273-227-8 | CAS number: 68953-84-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
Short description of key information:
1,4-Benzenediamine, N,N'-mixed Ph and tolyl derivs. was subjected to a guinea pig maximisation test (GPMT) according to OECD and GLP guidelines. The induction phase included both intradermal and epidermal exposures to test chemical plus adjuvant. Two epicutaneous challenges were performed at Day 21 and Day 28. Dermal edema, desquamation and blanching were observed in a high proportion of test animals. The results show that the test substance has sensitisation activity.Discussion
The key study was performed according to the Guinea-pig maximisation test as described in OECD test guideline 406, consisting of an intradermal and epidermal induction, and two epicutaneous challenges at day 21 and day 28.
The dermal response following 48h after the first challenge to 25% or 100% of chemical resulted in clinical effects (edema or desquamation) for 15% or 25% of test animals, respectively.
48 Hours after the second challenge 55% of the animals exposed to 25% of test chemical showed signs of desquamation, edema or blanching. In the test group exposed to 100% of test chemical, 75% of the animals showed signs of a sensitization reaction after 48 hours.
Justification for classification or non-classification
1,4-Benzenediamine, N,N'-mixed Ph and tolyl derivs. was subjected to a guinea pig maximisation test (GPMT) according to OECD and GLP guidelines. The induction phase included both intradermal and epidermal exposure to solutions of 5% test substance in acetone/propylene glycol.
The test animals did show clinical skin effects (dermal edema, desquamation, blanching) aftert both the Day 21 challenge and the Day 28 rechallenge trial. Individual responses were not strong, but up to 75% of the test animals did show signs of one or more of these skin responses. As a consequence, 1,4-benzenediamine, N,N'-mixed Ph and tolyl derivs. is to be classified as skin sensitiser Category 1B according to CLP Regulation (EC) No. 1272/2008 (amended according to Commission Regulation No 286/2011). Upon application of the potency criteria it can be concluded that the test substance shows moderate sensitisation.
When comparing the observed effects with the criteria specified in Directive 67/548/EEC (Dangerous Substances Directive), it can be concluded that the second criterion (positive result of at least 30% of the animals from an appropriate animal test) is fulfilled. As a consequence, 1,4-benzenediamine, N,N'-mixed Ph and tolyl derivs. is to be classified as a skin sensitiser according to Directive 67/548/EEC (Dangerous Substances Directive).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
Esta web utiliza cookies para mejorar su experiencia de navegación en nuestros sitios web.